Paolo Lisi Selected Research

Paolo Lisi Research Topics

4	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2015 - 06/2003
2	Urticaria (Hives) 09/2014 - 02/2008
2	Dermatitis 06/2014 - 06/2003
2	Hypersensitivity (Allergy) 08/2010 - 02/2008
2	Allergic Contact Dermatitis 01/2009 - 06/2003
2	Contact Dermatitis (Eczema, Contact) 02/2008 - 06/2003
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2015
1	Carotid Artery Diseases 08/2015
1	Drug Hypersensitivity Syndrome 04/2014
1	Eosinophilia 03/2013
1	Exanthema (Rash) 03/2013
1	Bullous Pemphigoid (Pemphigoid) 11/2012
1	Vasculitis (Vasculitides) 07/2010
1	Skin Diseases (Skin Disease) 03/2010
1	Drug Eruptions (Drug Eruption) 05/2009
1	Asthma (Bronchial Asthma) 02/2008
1	Aphthous Stomatitis (Aphthous Ulcer) 04/2004
1	Photoallergic Dermatitis (Photoallergy) 04/2004
1	Atopic Dermatitis (Atopic Eczema) 06/2003
1	Seborrheic Dermatitis 06/2003

2	Pharmaceutical PreparationsIBA 03/2013 - 07/2010
1	erucylphosphocholineIBA 08/2015
1	C-Reactive ProteinIBA 08/2015
1	Dimethyl FumarateIBA 09/2014
1	AllergensIBA 06/2014
1	Everolimus FDA Link 04/2014
1	CytokinesIBA 03/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2012
1	AcidsIBA 08/2010
1	Simvastatin (Zocor)FDA LinkGeneric 07/2010
1	Etanercept (Enbrel)FDA Link 01/2010
1	Celecoxib (Celebrex)FDA Link 05/2009
1	potassium metabisulfite FDA Link 01/2009
1	4,4'-diphenylmethane diisocyanate (methylene diphenyl diisocyanate)IBA 02/2008
1	QuinonesIBA 02/2008
1	calcipotriol drug combination betamethasone dipropionate FDA Link 01/2007
1	calcipotriene (calcipotriol)FDA LinkGeneric 01/2007
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 01/2007
1	Piroxicam (Feldene)FDA LinkGeneric 04/2004
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2004
1	Irritants (Vesicants)IBA 06/2003

1	Stents 04/2014
1	Therapeutics 03/2010